Mounjaro has officially overtaken Merck’s Keytruda to become the world’s best-selling drug, marking a major shift in the global pharmaceutical market. The blockbuster diabetes treatment from Eli Lilly & Co. generated USD 8.7 billion in sales...
Ajanta Pharma reported strong growth in its Ajanta Pharma Q4 results, with both domestic and global businesses driving performance for the quarter ended March 31, 2026. Revenue from operations rose 21 percent year-on-year to Rs 1,422 crore...
Emcure Pharmaceuticals reported a strong finish to the fiscal year, with Q4 profit showing a 24 percent year-on-year rise in net profit to Rs 243.74 crore. The company’s latest earnings highlight steady business momentum driven by solid demand...
OneSource partners have secured Canada approval, generic semaglutide injection, a major step that could make diabetes treatment more affordable while boosting competition in the rapidly growing GLP-1 drug market.
Takeda Pharmaceutical Company reported new data today showing its Takeda immune drug TAK-881 performs as effectively as an already approved treatment in patients with primary immunodeficiency (PID).
RPG Life Sciences is sharpening its strategy today with a strong focus on its GLP-1 entry plan and expanding API business, signaling a shift toward high-growth pharmaceutical segments. The company is looking to strengthen its position in active...
Granules India reported a strong finish to FY26, with Granules India Q4 profit rising 33 percent year-on-year to Rs 201 crore. The company’s performance reflects solid demand, improved margins, and steady execution across key business segments.
Artificial intelligence-focused biotech company Profluent has partnered with pharmaceutical major Eli Lilly and Company in a genetic medicine deal worth up to $2.25 billion. The collaboration aims to develop advanced gene-editing therapi...
Akums Drugs & Pharmaceuticals Limited has announced the launch of Aztreonam-Avibactam Injection, a new antibiotic therapy designed to tackle multidrug-resistant gram-negative bacterial infections. The move comes at a time when rising...
India’s Sun Pharmaceutical Industries has announced a major Sun Pharma Organon acquisition, agreeing to buy U.S.-based Organon & Co. in an all-cash deal valued at USD 11.75 billion, including debt. The company will pay USD 14 per share to acquire...
.jpg)
.jpg)
, CDSCO.jpg)